CONA
UTHR icon

Capital One National Association’s United Therapeutics UTHR Stock Holding History

Capital One National Association’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,569
Closed -$872K – 541
2015
Q4 		$872K Buy
+5,569
New +$811K 0.08% 236
2015
Q1 		– Sell
-1,637
Closed -$212K – 594
2014
Q4 		$212K Sell
1,637
-225
-12% -$29K 0.02% 509
2014
Q3 		$240K Sell
1,862
-11,268
-86% -$1.16M 0.02% 457
2014
Q2 		$1.16M Sell
13,130
-27
-0.2% -$2.6K 0.11% 212
2014
Q1 		$1.24M Sell
13,157
-44
-0.3% -$4.5K 0.12% 203
2013
Q4 		$1.49M Sell
13,201
-282
-2% -$25.4K 0.14% 180
2013
Q3 		$1.06M Sell
13,483
-1,247
-8% -$91.1K 0.11% 226
2013
Q2 		$970K Buy
+14,730
New +$949K 0.1% 232

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital One National Association's UTHR Position: Q1 2016 in Review

Capital One National Association sold out of United Therapeutics (UTHR) in Q1 2016, closing a stake of 5,569 shares — an estimated $872K sold.

Capital One National Association first reported a position in UTHR in Q2 2013 and held it in 8 quarters. The position peaked at $1.49M in Q4 2013. 398 funds tracked by Wall St. Rank hold UTHR as of Q1 2016.

  • Capital One National Association reported no remaining United Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Capital One National Association sold 5,569 United Therapeutics shares in Q1 2016, an estimated $872K.
  • Capital One National Association first reported a position in United Therapeutics in Q2 2013 and held it in 8 quarters.
  • Capital One National Association's United Therapeutics position peaked at $1.49M in Q4 2013.
  • 398 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2016.

Based on Capital One National Association's 13F filing for Q1 2016, filed 18 Apr 2016.